Mukta Arora

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 22

Top Topics

Acute Myeloid Leukemia

Multiple Myeloma

Intellectual Disability

Top Venues

Leukemia & lymphoma

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Aurore Perrot, Sosana Delimpasi, Emmanouil Spanoudakis, Ulf Frølund, Angelo Belotti, Albert Ortiol, Phillipe Moreau, Ian McFadden, Qing Xia, Mukta Arora, Meletios- Athanasios Dimopoulos
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study. Leukemia & lymphoma (2024)
Aurore Perrot, Sosana Delimpasi, Emmanouil Spanoudakis, Ulf Frølund, Angelo Belotti, Albert Ortiol, Phillipe Moreau, Ian McFadden, Qing Xia, Mukta Arora, Meletios- Athanasios Dimopoulos
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study. Leukemia & lymphoma (2024)
Aurore Perrot, Sosana Delimpasi, Emmanouil Spanoudakis, Ulf Frølund, Angelo Belotti, Albert Ortiol, Phillipe Moreau, Ian McFadden, Qing Xia, Mukta Arora, Meletios- Athanasios Dimopoulos
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study. Leukemia & lymphoma 65 (6) (2024)
Aurore Perrot, Sosana Delimpasi, Emmanouil Spanoudakis, Ulf Frølund, Angelo Belotti, Albert Ortiol, Phillipe Moreau, Ian McFadden, Qing Xia, Mukta Arora, Meletios- Athanasios Dimopoulos
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study. Leukemia & lymphoma 65 (6) (2024)
Aurore Perrot, Sosana Delimpasi, Emmanouil Spanoudakis, Ulf Frølund, Angelo Belotti, Albert Ortiol, Phillipe Moreau, Ian McFadden, Qing Xia, Mukta Arora, Meletios- Athanasios Dimopoulos
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study. Leukemia & lymphoma 65 (6) (2024)
Smita Bhatia, Chen Dai, Lindsey Hageman, Jessica Wu, Elizabeth Schlichting, Arianna Siler, Erin Funk, Jessica Hicks, Shawn Lim, Nora Balas, Alysia Kristine Bosworth, Hok Sreng Te, Liton Francisco, Ravi Bhatia, Stephen J Forman, F Lennie Wong, Mukta Arora, Saro H Armenian, Daniel J Weisdorf, Wendy Landier
Financial Burden in Blood or Marrow Transplantation Survivors During the COVID-19 Pandemic: A BMTSS Report. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Smita Bhatia, Chen Dai, Wendy Landier, Lindsey Hageman, Jessica Wu, Elizabeth Schlichting, Arianna Siler, Erin Funk, Jessica Hicks, Shawn Lim, Nora Balas, Alysia Kristine Bosworth, Hok Sreng Te, Liton Francisco, Ravi Bhatia, Donna Salzman, Frederick D Goldman, Stephen J Forman, Daniel J Weisdorf, F Lennie Wong, Saro H Armenian, Mukta Arora
Trends in Late Mortality and Life Expectancy After Autologous Blood or Marrow Transplantation Over Three Decades: A BMTSS Report. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (18) (2022)
Saro H Armenian, Yanjun Chen, Lindsay Hageman, Jessica Wu, Wendy Landier, Alysia Kristine Bosworth, Liton Francisco, Elizabeth Schlichting, Ravi Bhatia, Donna Salzman, F Lennie Wong, Daniel J Weisdorf, Stephen J Forman, Mukta Arora, Smita Bhatia
Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (28) (2022)
Najla El Jurdi, Grigori Okoev, Todd E DeFor, Shernan G Holtan, Brian C Betts, Bruce R Blazar, Claudio G Brunstein, Margaret L MacMillan, Daniel J Weisdorf, Mukta Arora
Predictors and outcomes of flares in chronic graft-versus-host disease. Bone marrow transplantation 57 (5) (2022)
Carrie L Kitko, Mukta Arora, Zachariah DeFilipp, Mohammad Abu Zaid, Antonio Di Stasi, Vedran Radojcic, Courtney B Betts, Lisa M Coussens, Michael L Meyers, Hope Qamoos, Peter Ordentlich, Vinit Kumar, Christine Quaranto, Aaron Schmitt, Yu Gu, Bruce R Blazar, Trent P Wang, Amandeep Salhotra, Iskra Pusic, Madan Jagasia, Stephanie J Lee
Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Nora Balas, Lindsey Hageman, Jessica Wu, Liton Francisco, Elizabeth Schlichting, Alysia Kristine Bosworth, Hok Sreng Te, F Lennie Wong, Wendy Landier, Donna Salzman, Daniel J Weisdorf, Stephen J Forman, Mukta Arora, Saro H Armenian, Smita Bhatia
Conditioning intensity and probability of live birth after blood or marrow transplantation, a BMTSS report. Blood advances 6 (8) (2022)
Divya Bhargava, Cathleen Drilling, Todd E DeFor, Claudio G Brunstein, Bharat Thygarajan, Najla El Jurdi, Shernan G Holtan, Armin Rashidi, Erica Warlick, Vidhyalakshmi Ramesh, John Rogosheske, Mukta Arora, Smita Bhatia, Daniel J Weisdorf
Impact of CDC warning on co-prescribing of opioids and benzodiazepines in older allogeneic hematopoietic cell transplant recipients. Bone marrow transplantation 57 (7) (2022)
Corey Cutler, Stephanie J Lee, Sally Arai, Marcello Rotta, Behyar Zoghi, Aleksander Lazaryan, Aravind Ramakrishnan, Zachariah DeFilipp, Amandeep Salhotra, Wanxing Chai-Ho, Rohtesh Mehta, Trent Wang, Mukta Arora, Iskra Pusic, Ayman Saad, Nirav N Shah, Sunil Abhyankar, Carlos Bachier, John Galvin, Annie Im, Amelia A Langston, Jane Liesveld, Mark B Juckett, Aaron Logan, Levanto Schachter, Asif Alavi, Dianna Howard, Harlan W Waksal, John Ryan, David Eiznhamer, Sanjay K Aggarwal, Jonathan Ieyoub, Olivier Schueller, Laurie Green, Zhongming Yang, Heidi Krenz, Madan Jagasia, Bruce R Blazar, Steven Pavletic
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study. Blood 138 (22) (2022)
Radhika Gangaraju, Yanjun Chen, Lindsey Hageman, Jessica Wu, Liton Francisco, Michelle Kung, Daniel J Weisdorf, Stephen J Forman, Mukta Arora, Saro H Armenian, Smita Bhatia
Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model. Blood advances 5 (20) (2021)
Mahasweta Gooptu, Rizwan Romee, Andrew St Martin, Mukta Arora, Monzr M Al Malki, Joseph H Antin, Christopher N Bredeson, Claudio G Brunstein, Saurabh Chhabra, Ephraim J Fuchs, Nilanjan Ghosh, Michael R Grunwald, Christopher G Kanakry, Natasha Kekre, Joseph P McGuirk, Ian K McNiece, Rohtesh S Mehta, Marco B Mielcarek, Filippo Milano, Dipenkumar Modi, Ran Reshef, Scott R Solomon, Mark A Schroeder, Edmund K Waller, Yoshiro Inamoto, Robert J Soiffer, Mary Eapen
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis. Blood 138 (3) (2021)
Joseph Pidala, Lynn Onstad, Paul J Martin, Betty K Hamilton, Corey Cutler, Carrie L Kitko, Paul A Carpenter, George L Chen, Mukta Arora, Mary E D Flowers, Sally Arai, Amin Alousi, Jennifer White, David Jacobsohn, Iskra Pusic, Stephanie J Lee
Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survival. Blood advances 5 (22) (2021)
Zachariah DeFilipp, Amin M Alousi, Joseph A Pidala, Paul A Carpenter, Lynn E Onstad, Sally Arai, Mukta Arora, Corey S Cutler, Mary E D Flowers, Carrie L Kitko, George L Chen, Stephanie J Lee, Betty K Hamilton
Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium. Blood advances 5 (20) (2021)
Aleksander Lazaryan, Stephanie J Lee, Mukta Arora, Jongphil Kim, Brian C Betts, Farhad Khimani, Taiga Nishihori, Nelli Bejanyan, Hien Liu, Mohamed A Kharfan-Dabaja, Frederick L Locke, Rebecca Gonzalez, Michael D Jain, Marco L Davila, Lia Elena Perez, Asmita Mishra, Ariel Perez Perez, Karlie Balke, Ernesto Ayala, Leonel Ochoa, Omar Castaneda Puglianini, Rawan G Faramand, Melissa Alsina, Hany Elmariah, Michael Nieder, Hugo F Fernandez, Claudio Anasetti, Joseph Pidala
Phase 2 multicenter trial of ofatumumab and prednisone as initial therapy of chronic graft-vs-host disease. Blood advances (2021)
Mukta Arora, Yanjun Chen, Lindsey Hageman, Jessica Wu, Wendy Landier, Liton Francisco, Michelle Kung, Emily Ness, Alysia Bosworth, Merve Pamukcuoglu, Daniel J Weisdorf, Stephen J Forman, Saro H Armenian, Smita Bhatia
Morbidity burden in survivors of multiple myeloma who underwent autologous transplantation: A Bone Marrow Transplantation Survivor Study. Cancer 126 (14) (2020)
Mukta Arora, Yanjun Chen, Jessica Wu, Lindsey Hageman, Emily Ness, Michelle Kung, Liton Francisco, Alysia Bosworth, Daniel J Weisdorf, Stephen J Forman, Wendy Landier, Merve Pamukçuoğlu, Saro H Armenian, F Lennie Wong, Smita Bhatia
Longitudinal trajectory of frailty in blood or marrow transplant survivors: Report from the Blood or Marrow Transplant Survivor Study. Cancer 127 (5) (2020)
Hewan Belete, Linda J Burns, Ryan Shanley, Manju Nayar, Brian McClune, Aleksandr Lazaryan, Veronika Bachanova, Nelli Bejanyan, Celalettin Ustun, Claudio Brunstein, Daniel J Weisdorf, Mukta Arora
Transplantation related toxicity and mortality in older autologous hematopoietic cell transplantation recipients. American journal of hematology 92 (9) (2017)
Mukta Arora, Daniel J Weisdorf, Ryan M Shanley, Bharat Thyagarajan
Pharmacogenetics of steroid-responsive acute graft-versus-host disease. Clinical transplantation 31 (5) (2017)